How to interpret cardiac biomarkers in renal failure and elderly?

Area of Science:

• Cardiology
• Nephrology
• Biomarker Analysis

Background:

• Highly sensitive assays for cardiac troponins (hs-cTn) challenge their role as injury markers.
• Natriuretic peptides are standard for myocardial dysfunction but influenced by extracardiac factors.
• Chronic kidney disease (CKD) elevates these biomarkers, impacting diagnostic accuracy and risk stratification.

Purpose of the Study:

• To investigate the impact of age and renal function on hs-cTn and natriuretic peptide levels.
• To clarify the challenges in interpreting these biomarkers in the context of CKD.
• To assess their potential for cardiovascular risk stratification in CKD.

Main Methods:

• Analysis of circulating levels of hs-cTn and natriuretic peptides.
• Evaluation of the influence of demographic factors (age, gender) and renal function.
• Comparison of biomarker levels in CKD versus non-CKD populations.

Main Results:

• Circulating levels of hs-cTn and natriuretic peptides are significantly affected by age and renal function.
• Elevated levels in CKD patients may not indicate cardiac injury or dysfunction.
• Variability necessitates re-evaluation of diagnostic thresholds and risk stratification models.

Conclusions:

• Age and renal function are critical confounders for hs-cTn and natriuretic peptide interpretation.
• Current thresholds may require adjustment, particularly for CKD populations.
• Further research is needed to refine the use of these biomarkers for cardiovascular risk assessment in CKD.